Induction of paracrine signaling in metastatic melanoma cells by PPARγ agonist rosiglitazone activates stromal cells and enhances tumor growth

Journal: Cancer Research

Published: 2018-11-15

DOI: 10.1158/0008-5472.can-18-0912

Affiliations: 5

Authors: 14

Go to article
Institutions FC
Center for Integrative Genomics (CIG), UNIL, Switzerland 0.50
Ludwig Center for Cancer Research, UNIL, Switzerland 0.14
Department of Oncology, UNIL, Switzerland 0.14
University Hospital Zurich (UHZ), Switzerland 0.14
Comparative Pathology Platform (COMPATH), UniBE, Switzerland 0.07